• Host METTL9 Restricts Candida via Zincophore Methylation

  2026-07-22

  Bao et al. uncover a novel host antifungal defense: intestinal epithelial cells secrete METTL9, a histidine methyltransferase that methylates the fungal zincophore PRA1, thereby impairing zinc acquisition and restricting Candida albicans colonization. This catalytic, cross-kingdom mechanism establishes secreted methyltransferases as a new arm of innate mucosal immunity, carrying implications for antifungal drug resistance research and disease modeling.

• Quizartinib (AC220): Redefining FLT3 Inhibition in AML Resea

  2026-07-22

  Explore how Quizartinib (AC220) transcends conventional FLT3 inhibition, empowering translational acute myeloid leukemia (AML) research with mechanistic precision, flexible assay integration, and insights into resistance biology. This article delivers actionable guidance for designing next-generation FLT3 autophosphorylation inhibition assays, contextualizes Quizartinib’s selectivity, and bridges emerging concepts from regulated cell death pathways to the evolving landscape of translational oncology.

• Live-Dead Cell Staining: Precision Tools for Hypoxic Tumor M

  2026-07-21

  Discover how advanced live-dead cell staining enables robust assessment of cell viability in high-fidelity hypoxic tumor models and accelerates translational glioblastoma research. This article integrates mechanistic insights, workflow optimization, and strategic guidance for leveraging Calcein-AM and Propidium Iodide dual staining in the era of bioprinted disease microenvironments.

• Cabozantinib (XL184): Phosphoproteomic Precision in Tumor Ad

  2026-07-21

  Explore how Cabozantinib (XL184) reshapes tumor phosphoproteomics and cellular adaptation, offering profound mechanistic insights for advanced medullary thyroid and renal cell carcinoma research. This article uniquely translates timescale-dependent signaling remodeling into practical assay design.

• Carbohydrate-Decorated Nanoparticles for Macrophage Gene Del

  2026-07-20

  This study demonstrates that biodegradable nanoparticles decorated with specific carbohydrates can significantly enhance gene delivery to macrophages, a cell type central to many diseases yet notoriously difficult to transfect. The findings highlight how tailored surface modifications drive cellular uptake and transfection efficiency, with implications for targeted gene therapy in inflammatory and cancer contexts.

• Ivermectin in Parasitology and Tumor Immunity: Mechanistic I

  2026-07-20

  Explore the dual role of Ivermectin as a broad-spectrum anti-parasitic and a tool for understanding immune evasion in cancer. This article delivers advanced mechanistic analysis and experimental guidance, setting it apart from standard protocol-focused resources.

• Imatinib (STI571) in Signal Transduction and Kinase Assays

  2026-07-19

  Imatinib (STI571) from APExBIO stands out as a precision tool for dissecting tyrosine kinase signaling in cancer and cell signaling research. This guide offers actionable protocols, troubleshooting insights, and a workflow-anchored analysis rooted in the latest advances in mass spectrometry imaging and kinase pathway inhibition.

• BODIPY 581/591 C11: Ratiometric Probe for Lipid Peroxidation

  2026-07-18

  BODIPY 581/591 C11 enables precise, ratiometric measurement of lipid peroxidation and antioxidant capacity in live-cell and model membrane systems. Its red-to-green fluorescence shift uniquely distinguishes oxidative stress from other ROS signatures, empowering translational workflows in cardiovascular research and beyond.

• Optimizing Assays with (S)-1-(3-fluoro-4-(trifluoromethoxy)p

  2026-07-17

  This article explores scenario-driven best practices for using (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (SKU A8959) in cell viability and enzyme inhibition workflows. Drawing on published evidence and validated product attributes, it addresses reproducibility, protocol optimization, and supplier reliability, empowering researchers to achieve robust and interpretable data.

• Eltanexor (KPT-8602): Advancing XPO1 Inhibition for Cancer T

  2026-07-17

  This article explores the mechanistic, experimental, and translational dimensions of Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, for cancer research. We synthesize recent insights into its unique mode of action, discuss its competitive profile, and provide practical guidance for translational scientists aiming to leverage Eltanexor in disease models, with an outlook on the evolving landscape of nuclear export-targeted therapeutics.

• Eltanexor (KPT-8602): Optimizing XPO1 Inhibition in Cancer R

  2026-07-16

  Eltanexor (KPT-8602) is redefining cancer research by selectively inhibiting XPO1-mediated nuclear export with exceptional potency and tolerability. This guide provides actionable protocols and troubleshooting tips for leveraging Eltanexor in translational and preclinical oncology workflows, grounded in the latest mechanistic and experimental breakthroughs.

• SepM Mutations Enhance S. mutans Inhibition of S. gordonii

  2026-07-16

  Liu et al. (2024) reveal that specific SepM mutations in Streptococcus mutans clinical isolates increase the bacterium's ability to inhibit S. gordonii, a key player in oral biofilm ecology. Their findings clarify the molecular interplay between cariogenic and non-cariogenic oral bacteria and highlight the functional consequences of SepM genetic variation.

• Coumestrol: A Phytoestrogen Estrogen Receptor Antagonist in

  2026-07-15

  Coumestrol stands out as a rigorously validated phytoestrogen estrogen receptor antagonist, enabling precision induction of ferroptosis in rheumatoid arthritis fibroblast models. By bridging nuclear receptor modulation with actionable cell-based workflows, researchers can dissect inflammatory circuits and optimize SERM-based screening with confidence.

• Vaccinia Virus F1L Protein Blocks ZAKα-Driven NLRP1 Inflamma

  2026-07-15

  This study reveals that the vaccinia virus protein F1L specifically inhibits the ZAKα-dependent activation of the NLRP1 inflammasome, thereby subverting key innate immune defense mechanisms. These findings clarify how viral factors can bypass host immune barriers and offer new perspectives for research into inflammasome modulation.

• Ceruletide (Caerulein): Precision Tool for Pancreatic Resear

  2026-07-14

  Ceruletide, also known as Caerulein, is a synthetic decapeptide analog of cholecystokinin used for standardized modeling in pancreatic function research. Its high purity and reproducible CCK receptor agonism make it a cornerstone in gastrointestinal physiology studies and digestive disorder research.

15774 records 1/1052 page Next 12345 下5页 Last page